Citadel Advisors’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-85,148
Closed -$610K 10279
2018
Q4
$610K Buy
85,148
+77,530
+1,018% +$863K ﹤0.01% 6098
2018
Q3
$146K Sell
7,618
-19,350
-72% -$690K ﹤0.01% 8417
2018
Q2
$1.53M Sell
26,968
-8,222
-23% -$417K ﹤0.01% 4512
2018
Q1
$1.49M Buy
+35,190
New +$1.51M ﹤0.01% 4188
2017
Q4
Sell
-8,781
Closed -$391K 8713
2017
Q3
$391K Buy
+8,781
New +$400K ﹤0.01% 5669
2017
Q2
Sell
-34,846
Closed -$2.52M 8403
2017
Q1
$2.52M Buy
34,846
+17,713
+103% +$1.17M ﹤0.01% 2795
2016
Q4
$980K Buy
+17,133
New +$1.57M ﹤0.01% 3878
2016
Q2
Sell
-1,025
Closed -$86K 7728
2016
Q1
$86K Sell
1,025
-4
-0.4% -$330 ﹤0.01% 6085
2015
Q4
$102K Sell
1,029
-88,312
-99% -$9.47M ﹤0.01% 6659
2015
Q3
$11M Buy
89,341
+88,225
+7,905% +$12M 0.01% 1294
2015
Q2
$171K Sell
1,116
-377
-25% -$62.2K ﹤0.01% 6512
2015
Q1
$255K Sell
1,493
-2,333
-61% -$353K ﹤0.01% 5874
2014
Q4
$585K Sell
3,826
-138,231
-97% -$17.3M ﹤0.01% 4496
2014
Q3
$15.1M Buy
142,057
+49,481
+53% +$6.89M 0.02% 1081
2014
Q2
$14.1M Buy
+92,576
New +$12.3M 0.02% 1030
2014
Q1
Sell
-3,353
Closed -$585K 8118
2013
Q4
$585K Sell
3,353
-889
-21% -$153K ﹤0.01% 3825
2013
Q3
$684K Sell
4,242
-6,992
-62% -$1.1M ﹤0.01% 3490
2013
Q2
$1.49M Buy
+11,234
New +$1.59M ﹤0.01% 2773

Other funds holding ELGX

Citadel Advisors's ELGX Position: Q1 2019 in Review

Citadel Advisors sold out of Endologix Inc (ELGX) in Q1 2019, closing a stake of 85,148 shares — an estimated $610K sold.

Citadel Advisors first reported a position in ELGX in Q2 2013 and held it in 18 quarters. The position peaked at $15.1M in Q3 2014. 63 funds tracked by Wall St. Rank hold ELGX as of Q1 2019.

  • Citadel Advisors reported no remaining Endologix Inc position as of Q1 2019 after selling out during the quarter.
  • Citadel Advisors sold 85,148 Endologix Inc shares in Q1 2019, an estimated $610K.
  • Citadel Advisors first reported a position in Endologix Inc in Q2 2013 and held it in 18 quarters.
  • Citadel Advisors's Endologix Inc position peaked at $15.1M in Q3 2014.
  • 63 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2019.

Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.